Rakesh Malhotra1, Kianoush B Kashani2, Etienne Macedo1, Jihoon Kim3, Josee Bouchard4, Susan Wynn1, Guangxi Li5, Lucila Ohno-Machado3, Ravindra Mehta1. 1. Division of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, San Diego, CA, USA. 2. Division of Nephrology and Hypertension and Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA. 3. Division of Biomedical Informatics, Department of Medicine, University of California, San Diego, San Diego, CA, USA. 4. Service de Néphrologie, Département de médecine, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal, Québec, Canada. 5. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND: Acute kidney injury (AKI) is common in critically ill patients and is associated with high morbidity and mortality. Early identification of high-risk patients provides an opportunity to develop strategies for prevention, early diagnosis and treatment of AKI. METHODS: We undertook this multicenter prospective cohort study to develop and validate a risk score for predicting AKI in patients admitted to an intensive care unit (ICU). Patients were screened for predictor variables within 48 h of ICU admission. Baseline and acute risk factors were recorded at the time of screening and serum creatinine was measured daily for up to 7 days. A risk score model for AKI was developed with multivariate regression analysis combining baseline and acute risk factors in the development cohort (573 patients) and the model was further evaluated on a test cohort (144 patients). Validation was performed on an independent prospective cohort of 1300 patients. The discriminative ability of the risk model was assessed by the area under the receiver operating characteristic curve (AUROC) and model calibration was evaluated by Hosmer-Lemeshow statistic. AKI was defined by the Kidney Disease: Improving Global Outcomes criteria (absolute change of 0.3 mg/dL or relative change of 50% from baseline serum creatinine in 48 h to 7 days, respectively). RESULTS: AKI developed in 754 (37.2%) patients. In the multivariate model, chronic kidney disease, chronic liver disease, congestive heart failure, hypertension, atherosclerotic coronary vascular disease, pH ≤ 7.30, nephrotoxin exposure, sepsis, mechanical ventilation and anemia were identified as independent predictors of AKI and the AUROC for the model in the test cohort was 0.79 [95% confidence interval (CI) 0.70-0.89]. On the external validation cohort, the AUROC value was 0.81 (95% CI 0.78-0.83). The risk model demonstrated good calibration in both cohorts. Positive and negative predictive values for the optimal cutoff value of ≥ 5 points in test and validation cohorts were 22.7 and 96.1% and 31.8 and 95.4%, respectively. CONCLUSIONS: A risk score model integrating chronic comorbidities and acute events at ICU admission can identify patients at high risk to develop AKI. This risk assessment tool could help clinicians to stratify patients for primary prevention, surveillance and early therapeutic intervention to improve care and outcomes of ICU patients.
BACKGROUND: Acute kidney injury (AKI) is common in critically ill patients and is associated with high morbidity and mortality. Early identification of high-risk patients provides an opportunity to develop strategies for prevention, early diagnosis and treatment of AKI. METHODS: We undertook this multicenter prospective cohort study to develop and validate a risk score for predicting AKI in patients admitted to an intensive care unit (ICU). Patients were screened for predictor variables within 48 h of ICU admission. Baseline and acute risk factors were recorded at the time of screening and serum creatinine was measured daily for up to 7 days. A risk score model for AKI was developed with multivariate regression analysis combining baseline and acute risk factors in the development cohort (573 patients) and the model was further evaluated on a test cohort (144 patients). Validation was performed on an independent prospective cohort of 1300 patients. The discriminative ability of the risk model was assessed by the area under the receiver operating characteristic curve (AUROC) and model calibration was evaluated by Hosmer-Lemeshow statistic. AKI was defined by the Kidney Disease: Improving Global Outcomes criteria (absolute change of 0.3 mg/dL or relative change of 50% from baseline serum creatinine in 48 h to 7 days, respectively). RESULTS: AKI developed in 754 (37.2%) patients. In the multivariate model, chronic kidney disease, chronic liver disease, congestive heart failure, hypertension, atherosclerotic coronary vascular disease, pH ≤ 7.30, nephrotoxin exposure, sepsis, mechanical ventilation and anemia were identified as independent predictors of AKI and the AUROC for the model in the test cohort was 0.79 [95% confidence interval (CI) 0.70-0.89]. On the external validation cohort, the AUROC value was 0.81 (95% CI 0.78-0.83). The risk model demonstrated good calibration in both cohorts. Positive and negative predictive values for the optimal cutoff value of ≥ 5 points in test and validation cohorts were 22.7 and 96.1% and 31.8 and 95.4%, respectively. CONCLUSIONS: A risk score model integrating chronic comorbidities and acute events at ICU admission can identify patients at high risk to develop AKI. This risk assessment tool could help clinicians to stratify patients for primary prevention, surveillance and early therapeutic intervention to improve care and outcomes of ICU patients.
Authors: Sehoon Park; Hyunjeong Cho; Seokwoo Park; Soojin Lee; Kwangsoo Kim; Hyung Jin Yoon; Jiwon Park; Yunhee Choi; Suehyun Lee; Ju Han Kim; Sejoong Kim; Ho Jun Chin; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Hajeong Lee Journal: J Am Soc Nephrol Date: 2018-12-18 Impact factor: 10.121
Authors: Sami Safadi; Musab S Hommos; Felicity T Enders; John C Lieske; Kianoush B Kashani Journal: Mayo Clin Proc Date: 2020-01-31 Impact factor: 7.616
Authors: Andrew C McKown; Li Wang; Jonathan P Wanderer; Jesse Ehrenfeld; Todd W Rice; Gordon R Bernard; Matthew W Semler Journal: J Med Syst Date: 2017-08-31 Impact factor: 4.460
Authors: Lijuan Wu; Yong Hu; Borong Yuan; Xiangzhou Zhang; Weiqi Chen; Kang Liu; Mei Liu Journal: Int J Med Inform Date: 2020-09-11 Impact factor: 4.046
Authors: Y Diana Kwong; Kala M Mehta; Christine Miaskowski; Hanjing Zhuo; Kimberly Yee; Alejandra Jauregui; Serena Ke; Thomas Deiss; Jason Abbott; Kirsten N Kangelaris; Pratik Sinha; Carolyn Hendrickson; Antonio Gomez; Aleksandra Leligdowicz; Michael A Matthay; Carolyn S Calfee; Kathleen D Liu Journal: Am J Physiol Renal Physiol Date: 2020-10-12